Back to search

University of Toronto

Pharmacological and Structural Characterization of Zinc Finger Ubiquitin-Binding Domain Proteins

Abstract

dc:description.abstract

Drug discovery is expensive, not only in terms of total cost but also in time. Approval of novel compounds for therapeutic use is rare, often due to poor translation of pre-clinical findings to clinical efficacy. Focus on pre-clinical target selection and validation with high-quality chemical tools can enable better functional understanding of the biology of drug targets and result in higher quality drug-like molecules, saving time and money. Humans have many proteins involved in cell regulation through the ubiquitin proteasome and autophagy lysosomal pathway, where dysregulation is often associated with disease. A subset of these proteins have non-catalytic zinc finger ubiquitin-binding domain (ZnF-UBD), a unique fold that primarily binds ubiquitin or ubiquitinated substrates for various roles in maintaining cellular homeostasis. Drug discovery efforts have focused on developing catalytic inhibitors, with limited success. There is a lack of chemical tools to understand the biology and role of the non-catalytic ZnF-UBDs, and the potential to exploit these domains as a therapeutic strategy has been underexplored. I hypothesize it is possible to develop potent, selective, and cell-active chemical tool compounds for the ZnF-UBD of HDAC6 and USP5, two proteins implicated in several pathologies; this thesis focuses on developing chemical tools against the ZnF-UBD of HDAC6 and USP5, and to explore the structural dynamics of the USP5 ZnF-UBD to expand the field of ZnF-UBD biology. To address this objective, I used a combination of computational, biophysical, and structure-based approaches. I characterized a chemical series to identify the first chemical probe, SGC-UBD253, that specifically targets the HDAC6 ZnF-UBD. Next, I discovered, characterized, and optimized a chemical series of compounds that potently and specifically target the USP5 ZnF-UBD, and inhibit USP5 activity. I show that targeting the USP5 ZnF-UBD is a novel and promising strategy for USP5 inhibition. Finally, I examined the structural dynamics of USP5 and the ZnF-UBD to demonstrate there are different conformations of the protein, and ZnF-UBD dynamics may play a role in ubiquitin binding to influence cleavage of ubiquitin substrates. Taken together, these findings provide the tools for further research into the roles of ZnF-UBD proteins in health and disease.

Degree

thesis:*
Department dc:contributor.department
Pharmacology
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mann, Mandeep Kaur
Advisor dc:contributor.advisor
  • Schapira, Matthieu

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1807/128200

Chain of custody

source
Harvested from
University of Toronto
Base URL
utoronto.scholaris.ca/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Mann, Mandeep Kaur. Pharmacological and Structural Characterization of Zinc Finger Ubiquitin-Binding Domain Proteins. 2023. http://hdl.handle.net/1807/128200